Orchestra BioMed News

Orchestra BioMed Hldgs Analyst Ratings

BenzingaJun 12 07:40 ET

Orchestra BioMed Hldgs Analyst Ratings

BenzingaMar 28 08:51 ET

Piper Sandler Sticks to Its Buy Rating for Orchestra BioMed Holdings (OBIO)

TipRanksMar 28 07:01 ET

Buy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT Clinical Data

TipRanksMar 27 19:40 ET

Orchestra BioMed Hldgs Analyst Ratings

BenzingaJan 19 06:26 ET

Buy Rating for Orchestra BioMed Holdings: An Optimistic Outlook on BACKBEAT and Virtue SAB Studies' Potential Impact and Future Developments

TipRanksNov 20, 2023 11:06 ET

Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO) and Bicycle Therapeutics (BCYC)

TipRanksNov 13, 2023 21:10 ET

Analysts Offer Insights on Healthcare Companies: Reneo Pharmaceuticals (RPHM), Pulmonx (LUNG) and Orchestra BioMed Holdings (OBIO)

TipRanksOct 11, 2023 07:02 ET

Orchestra BioMed Holdings (OBIO) Gets a Buy From LifeSci Capital

TipRanksSep 19, 2023 15:25 ET

LifeSci Capital Sticks to Their Buy Rating for Orchestra BioMed Holdings (OBIO)

TipRanksAug 14, 2023 17:15 ET

Orchestra BioMed Hldgs Analyst Ratings

BenzingaAug 11, 2023 06:56 ET

Orchestra BioMed Hldgs Analyst Ratings

BenzingaAug 9, 2023 04:23 ET

Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), Anavex Life Sciences (AVXL) and Recursion Pharmaceuticals (RXRX)

TipRanksAug 8, 2023 10:50 ET

Orchestra BioMed Holdings (OBIO) Gets a Buy From Chardan Capital

TipRanksJul 3, 2023 05:45 ET

LifeSci Capital Reaffirms Their Buy Rating on Orchestra BioMed Holdings (OBIO)

TipRanksMay 15, 2023 20:15 ET

Chardan Capital Reiterates Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target

BenzingaMay 15, 2023 04:29 ET

Chardan Capital Reaffirms Their Buy Rating on Orchestra BioMed Holdings (OBIO)

TipRanksMay 14, 2023 21:05 ET

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN) and Orchestra BioMed Holdings (OBIO)

TipRanksMar 8, 2023 14:58 ET

Orchestra BioMed Hldgs Analyst Ratings

BenzingaFeb 24, 2023 09:08 ET

Piper Sandler Initiates Coverage On Orchestra BioMed Hldgs With Overweight Rating, Announces Price Target of $15

BenzingaFeb 24, 2023 08:53 ET